Three scientists at the School of Medicine and Siteman Cancer Center will receive $600,000 in funding over two years for their innovative approach to detecting a type of advanced prostate cancer.
A test exists that detects resistant tumors in metastatic prostate cancer patients; however, the funding from the Alvin J. Siteman Cancer Research Fund is meant to speed development of a more advanced test that aims to identify these cancers earlier and with better sensitivity. The recipients are: Aadel Chaudhuri, MD, PhD; Christopher Maher; and Russell Pachynski, MD. Read more on the Siteman website.
